Business Insider

Akero Therapeutics and InSphero partner to evaluate AKR-001 using InSphero's 3D InSight™ Human Liver Disease platform

SCHLIEREN, Switzerland and SAN FRANCISCO, Oct. 3, 2019 /PRNewswire/ -- Akero Therapeutics and InSphero AG today announced that Akero has selected InSphero's 3D InSight™ Human Liver Disease Platform to ...
Business Insider

InSphero offers free safety testing in 3D InSight™ Human Liver Models for exploratory COVID-19 treatments

SCHLIEREN, Switzerland, March 24, 2020 /PRNewswire/ -- InSphero AG, the pioneer of 3D cell-based assay technology, today announced that it will offer free safety testing for exploratory COVID-19 ...
PR Newswire

InSphero and FDA's NCTR Publish the Largest Benchmarking Study Demonstrating Early Detection of Liver Toxicity Using 3D Liver Microtissues

ZURICH, Oct. 15, 2024 /PRNewswire/ -- InSphero, the global leader in 3D cell culture technology, and scientists from the U.S. Food and Drug Administration's (FDA) National Center for Toxicological ...
The Indianapolis Star

InSphero and PharmaNest From a Partnership to Advance Translational Fibrosis Research

SCHLIEREN, ZURICH, SWITZERLAND, February 11, 2026 /EINPresswire.com/ — InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems ...
Healio

InSphero launches NAFLD, NASH cellular drug development platform

Please provide your email address to receive an email when new articles are posted on . InSphero AG announced the launch of 3D InSight Human Liver Disease Discovery Platform, a 3D cell technology for ...